Searchable abstracts of presentations at key conferences in endocrinology

ea0011p631 | Neuroendocrinology and behaviour | ECE2006

Pro-opiomelanocortin and ACTH, precursors of alphaMSH, are secreted from human melanocytes and keratinocytes and can stimulate melanogenesis

Rousseau K , Kauser S , Prtichard LE , Warhurst A , Oliver RL , Schmitz CA , Thody AJ , Tobin DJ , White A

Pro-opiomelanocortin (POMC) is endoproteolysed to ACTH and alpha MSH which bind to the melanocortin-1 receptor, (MC-1R), and act as principal mediators of human skin pigmentation. In addition there is increasing evidence that alpha MSH has important anti-inflammatory actions in the skin. The aim of this study was to determine the efficiency of processing and the involvement of the different peptides in melanogenesis. To address this question we utilized specific two-site immun...

ea0011p727 | Steroids | ECE2006

High risk of adrenal insufficiency after single intra- or peri-articular steroid administration in young healthy sportsmen

Duclos M , Guinot M , Colsy M , Merle F , Corcuff JB , Le Bouc Y

Objectives: To determine if a single intra- or peri-articular injection of corticosteroid for post-traumatic or microtraumatic skeleton injuries in healthy young subjects would induce a suppression of hypothalamo-pituitary-adrenal axis activity and reactivity.Methods: 10 young healthy male sportsmen (28.8±2.5 years) received a single intra- or peri-articular injection of either cortivazol or betamethasone for post-traumatic or microtraumatic skeleto...

ea0011p763 | Steroids | ECE2006

Glucocorticoid receptors exert a profound anti-proliferative and anti-survival effect on human small cell lung cancer cells

Le Rouzic P , Gillingham H , Berry A , Kayahara M , Huynh T , Sommer P , White A , Ray DW

Glucocorticoids (Gcs) act via the glucocorticoid receptor (GR) to inhibit proliferation of many epithelial cell types, and induce apoptosis in others, notably lymphoblastic leukemia. Resistance to Gcs occurs in human small cell lung cancer (SCLC), manifest clinically as dysregulated secretion of ACTH-related peptides. Currently nothing is known of the biological consequences such resistance causes. We have previously shown that a panel of human SCLC cell lines secrete ACTH rel...

ea0010oc5 | Reproduction, neuroendocrinology and diabetes | SFE2005

Fasting and postprandial peptide YY response in adolescents with obesity

le Roux C , Wickramasuriya B , Ghatei M , Bloom|K##Matyka S

BackgroundThe gut hormone peptide YY (PYY) is released postprandially acting as a satiety signal. Obese adults have reduced concentrations of PYY in the fasting and postprandial state. Animal data suggest that lower PYY levels are likely to be a consequence rather than a cause of obesity. We aimed to investigate PYY in the fasting state and after a 420 kcal meal in post pubertal children.MethodNine normal wei...

ea0009oc5 | Oral Communication 1: Diabetes and metabolism | BES2005

Changes in gut hormones after Roux-en-Y gastric bypass for morbid obesity favour an anorectic state

Borg C , le Roux C , Ghatei M , Bloom S , Patel A , Aylwin S

ObjectiveBariatric surgery has an important role in the management of morbidly obese patients. Roux-en-Y gastric bypass (RYGB) is an established bariatric procedure. In this study, we aimed to investigate prospective changes in the entero-hypothalamic endocrine axis following RYGB, examining the meal-stimulated responses of peptide-YY (PYY), glucagon-like peptide 1 (GLP-1) and ghrelin.MethodsSix female patien...

ea0009p56 | Growth and development | BES2005

Obese subjects have lower satiety

Giles C , le Roux C , Aylwin S , Hunt C , Ghatei M , Frost G , Bloom S

Background: Obese subjects are usually in a positive energy balance despite their best efforts to lose weight. This study aimed to determine if hunger, nausea and satiety levels differ in lean and obese subjects after consuming varying calorific meals.Method: Following an overnight fast, test meals of 250, 500, 1000, 2000 and 3000 kcal were consumed by 19 lean and 19 obese subjects. Hunger, nausea and satiety levels were measured using visual analogue sc...

ea0009p133 | Steroids | BES2005

Modulation of glucocorticoid sensitivity by retroviral gene transfer

Le Rouzic P , Gillingham H , Berry A , Garside H , White A , Ray D

Glucocorticoid sensitivity is dependent on the intracellular concentration of the glucocorticoid receptor (GR). GR expression is regulated in a complex, cell-type specific manner, but in most cell types the GR is subject to negative autoregulation by glucocorticoid exposure. Many human diseases are associated with reduced tissue sensitivity to glucocorticoids, including inflammatory arthritis, asthma, and chronic obstructive pulmonary disease. Therefore there is interest in ap...

ea0056oc6.3 | Genetic and environmental determinants of obesity and insulin resistance | ECE2018

Visceral fat assessment in lamin A/C mutation carriers: phenotype –genotype correlation

Kwapich Maxime , Espiard Stephanie , Le Mapihan Kristell , Vigouroux Corinne , Vantyghem Marie-Christine

Background: Lamin A/C mutations show heterogeneous phenotypes expanding from cardiopathies to lipodystrophies. R482-LMNA gene mutation is the hot-spot for familial partial lipodystrophic syndromes (FPLD2) and is characterized by an increase of intra-abdominal (visceral) fat. In contrast, the visceral fat phenotype of non-R482-LMNA mutated patients has not been well studied.Objectives: To compare the fat amount and visceral repartition o...

ea0056p651 | Endocrine tumours and neoplasia | ECE2018

Targeting Treatment Resistance in Breast Cancer Subtypes via LMTK3 Inhibition

Ditsiou Angeliki , Gagliano Teresa , Prodromou Chrisostomos , Gascon Jose , Mumford Sophie , Grand Darren Le , Giamas Georgios

Introduction: LMTK3 is an oncogenic Receptor Tyrosine Kinase (RTK) implicated in resistance to endocrine therapy in breast cancer. Initially, LMTK3 was described as a regulator of Estrogen Receptor alpha (ERα) since it was found able to protect it from ubiquitin-mediated proteasomal degradation. In a cohort of breast cancer (BC) patients (n>600), LMTK3 protein levels and intronic polymorphisms were significantly associated with disease-free and overall surviv...

ea0092ps3-24-09 | Thyroid Eye Disease | ETA2023

Clinical conditions related to the short, medium and long term clinical outcome of moderate/severe graves’ ophthalmopathy to parenteral glucocorticoids: a retrospective study

Naselli Adriano , Costanzo Gabriele , Belfiore Antonino , Frasca Francesco , Le Moli Rosario

Introduction: Oxidative stress (OX) plays a role in the pathogenesis of moderate to severe Graves’ ophthalmopathy (AMS-GO).Aim: We evaluated the impact of clinical conditions related to OX on the outcome of parenteral glucocorticoids (PGLUC) therapy in AMS-GO.Methods: We retrospectively evaluated patients with AMS-GO treated with PGLUC from January 2013 to May 2022. GO clinical evaluation was performed at baseline, at 6 (W6), ...